Assessment and management of behavioral and psychological symptoms of dementia
By H. Kales, L. Gitlin, C. Lyketsos. British medical journal, 2015
1,081 citations recorded by the source corpus.
Behavioral and psychological symptoms of dementia include agitation, depression, apathy, repetitive questioning, psychosis, aggression, sleep problems, wandering, and a variety of inappropriate behaviors. One or more of these symptoms will affect nearly all people with dementia over the course of their illness. These symptoms are among the most complex, stressful, and costly aspects of care, and they lead to a myriad of poor patient health outcomes, healthcare problems, and income loss for family care givers. The causes include neurobiologically related disease factors; unmet needs; care giver factors; environmental triggers; and interactions of individual, care giver, and environmental factors. The complexity of these symptoms means that there is no “one size fits all solution,” and approaches tailored to the patient and the care giver are needed. Non-pharmacologic approaches should be used first line, although several exceptions are discussed. Non-pharmacologic approaches with the strongest evidence base involve family care giver interventions. Regarding pharmacologic treatments, antipsychotics have the strongest evidence base, although the risk to benefit ratio is a concern. An approach to integrating non-pharmacologic and pharmacologic treatments is described. Finally, the paradigm shift needed to fully institute tailored treatments for people and families dealing with these symptoms in the community is discussed.
Subfields: Clinical Psychology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/fa2692617bb8e99d97bb96b900a993aace8f45d8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- Alzheimer's disease (2018, background): “Atypical antipsychotics are usually favoured over typical agents but, regardless of drug, benefits are moderate [67], and no treatments are licensed for behavioural symptoms in dementia.”